Jimmy Kimmel will host the Oscars for the third time, with hopes for a smoother event compared to last year’s controversial incident where Will Smith slapped host Chris Rock. Kimmel first hosted the event in 2017 during the infamous “envelopegate” and in 2018 before the Oscars went without a host for three years. Despite falling ratings, last year’s first full ceremony after the pandemic saw a slight improvement. Kimmel expressed his gratitude for the Academy inviting him back, saying that being asked to host for the third time is either a great honor or a trap. Executive producers Glenn Weiss and Ricky Kirshner are thrilled to have Kimmel back, stating that they know he will be ready for anything and bring his trademark humor to the global stage.
It is rare for the Oscars to feature discussions on drugs and healthcare, but presenter Jimmy Kimmel made a lighthearted reference to the diabetes drug, Ozempic, during his opening monologue. Kimmel jokingly mentioned the drug’s rumored use as a weight loss solution by Hollywood celebrities, wondering aloud if it would be suitable for himself. While Kimmel’s comment was made in jest, it highlights a serious issue about the potential misuse of the drug for cosmetic purposes, rather than its intended medical benefits.
The use of Ozempic, an injectable prescription drug, for weight loss is a controversial topic. While GLP receptor agonist drugs like Ozempic can aid in weight loss and manage diabetes-related issues, their usage should be supervised and guided by a healthcare professional, as side effects can be unpleasant. “Although GLP receptor agonist drugs are not yet available in India, they are beneficial for weight loss and can help manage diabetes-related problems. However, they should only be used based on medical indication, as side effects can include nausea, vomiting, and rarely, pancreatic inflammation,” says Dr. Anoop Misra, Chairman of Fortis CDOC Hospital for Diabetes and Allied Sciences.
The newly-approved weight-loss medication Semaglutide, marketed under the brand names Ozempic and Wegovy, has garnered attention for its impressive results in reducing body weight and improving cardiovascular health in patients with Type 2 diabetes. With obesity rates projected to rise in India, Semaglutide offers a promising solution to this growing health concern. According to Dr. Misra, Semaglutide can help individuals lose up to 15-20% of their body weight, a significant result not achievable with other interventions aside from bariatric surgery. While other weight loss drugs exist on the market, Semaglutide has proven to be the most effective, particularly for individuals with a history of obesity and related health issues. Dr. Misra suggests that the drug should be prescribed to those who have not seen significant results with diet and exercise due to their weight and related joint pains. Semaglutide may just be the weight-loss “magic bullet” that India needs to combat its growing obesity crisis.
According to Dr. Misra, the diabetes drug, Ozempic, should not be the primary solution for treating obesity. Furthermore, he predicts that the medication may be expensive in India when it becomes available in the next few months, likely costing between Rs 8000 to Rs 9000 per month. Additionally, it may cause unpleasant gastrointestinal side effects like nausea, vomiting, and diarrhea in the first few weeks. Dr. Misra recommends that the drug should only be prescribed to three specific categories of people: those who are obese and have related disorders like diabetes or fatty liver disease, those who are unable to lose weight through traditional methods, and those who are obese with uncontrolled diabetes despite medication. He emphasizes that the medication should not be given to everyone who is overweight or obese.
According to a report by Insider’s Anna Miller, business magnate Elon Musk attributed his weight loss and improved health to “fasting” and taking the diabetes drug semaglutide, which is sold under the brand name Wegovy. In October 2022, Musk tweeted that he was taking this particular brand of the drug. Musk has previously described semaglutide as helping him get “fit, ripped, and healthy.”
During an appearance on the “Call Her Daddy” podcast in January 2023, comedian Chelsea Handler revealed that she took the diabetes drug semaglutide without realizing what it was. According to Handler, her “anti-aging doctor” prescribed it to her, saying that it was good for losing weight. However, when Handler mentioned feeling nauseous and taking something called semaglutide to a friend who was also using the drug, her friend informed her that semaglutide is sold under the brand name Ozempic. Handler ultimately decided to discontinue her use of the drug.
In response to an accusation made by a commenter on Instagram in January 2023 that she takes diabetes medication to achieve weight loss, reality TV star Khloe Kardashian defended her hard work and dedication to exercise. According to Buzzfeed, Kardashian posted an image of herself on the cover of Sorbet magazine on Instagram, and a commenter accused her of using diabetic medication to lose weight. Kardashian responded by stating that she has been working out for years, training five days a week at 6 am, and asking people to stop making assumptions about her methods.
More Entertainment News:
For more latest and trending entertainment news check out our entertainment section